Angeline Bartholomeusz

5.0k total citations
53 papers, 4.0k citations indexed

About

Angeline Bartholomeusz is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Angeline Bartholomeusz has authored 53 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Epidemiology, 48 papers in Hepatology and 18 papers in Infectious Diseases. Recurrent topics in Angeline Bartholomeusz's work include Hepatitis B Virus Studies (48 papers), Hepatitis C virus research (48 papers) and Liver Disease Diagnosis and Treatment (16 papers). Angeline Bartholomeusz is often cited by papers focused on Hepatitis B Virus Studies (48 papers), Hepatitis C virus research (48 papers) and Liver Disease Diagnosis and Treatment (16 papers). Angeline Bartholomeusz collaborates with scholars based in Australia, United States and Germany. Angeline Bartholomeusz's co-authors include Stephen Locarnini, Anna Ayres, Stephan Schaefer, Timothy J. Shaw, Fabien Zoulim, Peter Angus, Stephen Locarnini, P.J. Wright, Sharon R. Lewin and Janine McMillan and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Virology.

In The Last Decade

Angeline Bartholomeusz

53 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angeline Bartholomeusz Australia 34 3.7k 3.5k 1.1k 157 156 53 4.0k
Stephen Locarnini Australia 23 3.6k 1.0× 3.4k 1.0× 736 0.7× 181 1.2× 61 0.4× 54 4.0k
George G. Schlauder United States 19 1.7k 0.5× 2.9k 0.8× 1.4k 1.3× 157 1.0× 66 0.4× 33 3.3k
Anna Kramvis South Africa 36 4.2k 1.1× 3.8k 1.1× 513 0.5× 81 0.5× 48 0.3× 115 4.5k
Gavin Cloherty United States 25 1.4k 0.4× 1.3k 0.4× 785 0.7× 293 1.9× 92 0.6× 179 2.2k
Carla Osiowy Canada 24 1.5k 0.4× 1.3k 0.4× 602 0.5× 46 0.3× 186 1.2× 97 2.0k
Doris C. Wong United States 19 2.0k 0.5× 2.3k 0.6× 586 0.5× 183 1.2× 40 0.3× 26 2.8k
Michelle L. Chalmers United States 16 1.5k 0.4× 1.4k 0.4× 810 0.7× 127 0.8× 54 0.3× 20 2.4k
J. Saldanha United Kingdom 22 1.1k 0.3× 912 0.3× 755 0.7× 115 0.7× 316 2.0× 67 1.9k
Scott Muerhoff United States 5 1.5k 0.4× 1.6k 0.5× 586 0.5× 145 0.9× 297 1.9× 5 2.2k
Erwin Sablon Belgium 33 2.6k 0.7× 2.5k 0.7× 422 0.4× 34 0.2× 75 0.5× 79 3.4k

Countries citing papers authored by Angeline Bartholomeusz

Since Specialization
Citations

This map shows the geographic impact of Angeline Bartholomeusz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angeline Bartholomeusz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angeline Bartholomeusz more than expected).

Fields of papers citing papers by Angeline Bartholomeusz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angeline Bartholomeusz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angeline Bartholomeusz. The network helps show where Angeline Bartholomeusz may publish in the future.

Co-authorship network of co-authors of Angeline Bartholomeusz

This figure shows the co-authorship network connecting the top 25 collaborators of Angeline Bartholomeusz. A scholar is included among the top collaborators of Angeline Bartholomeusz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angeline Bartholomeusz. Angeline Bartholomeusz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Sheldon, Julie, Belén Ramos, Javier García‐Samaniego, et al.. (2007). Selection of Hepatitis B Virus (HBV) Vaccine Escape Mutants in HBV-Infected and HBV/HIV-Coinfected Patients Failing Antiretroviral Drugs With Anti-HBV Activity. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(3). 279–282. 51 indexed citations
3.
Lok, Anna S., Fabien Zoulim, Stephen Locarnini, et al.. (2007). Antiviral drug-resistant HBV. Hepatology. 46(1). 254–265. 349 indexed citations
4.
Thompson, Alexander, Anna Ayres, Lilly Yuen, et al.. (2006). Lamivudine resistance in patients with chronic hepatitis B: Role of clinical and virological factors. Journal of Gastroenterology and Hepatology. 22(7). 1078–1085. 34 indexed citations
5.
Shaw, Timothy J., Angeline Bartholomeusz, & Stephen Locarnini. (2006). HBV drug resistance: Mechanisms, detection and interpretation. Journal of Hepatology. 44(3). 593–606. 177 indexed citations
6.
Chan, Henry Lik‐Yuen, Stephen Kwok‐Wing Tsui, Chi‐Hang Tse, et al.. (2005). Epidemiological and Virological Characteristics of 2 Subgroups of Hepatitis B Virus Genotype C. The Journal of Infectious Diseases. 191(12). 2022–2032. 82 indexed citations
7.
Hui, Chee‐Kin, Wing Y. Au, Haiying Zhang, et al.. (2005). Sexual transmission of hepatitis B infection despite the presence of hepatitis B virus immunity in recipients of allogeneic bone marrow transplantation. Journal of Clinical Virology. 32(2). 173–178. 5 indexed citations
8.
Ayres, Anna, Stephen Locarnini, & Angeline Bartholomeusz. (2004). HBV Genotyping and Analysis for Unique Mutations. Humana Press eBooks. 95. 125–150. 34 indexed citations
9.
Bell, Sally, Audrey Lau, A. Thompson, et al.. (2004). Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients. Journal of Clinical Virology. 32(2). 122–127. 23 indexed citations
10.
Bartholomeusz, Angeline & Stephan Schaefer. (2004). Hepatitis B virus genotypes: comparison of genotyping methods. Reviews in Medical Virology. 14(1). 3–16. 158 indexed citations
11.
Xiong, S., C. Westland, William E. Delaney, et al.. (2003). Resistance surveillance of HBEAG— chronic hepatitis B (CHB) patients treated for two years with adefovir dipivoxil (ADV). Journal of Hepatology. 38. 182–182. 35 indexed citations
12.
Locarnini, Stephen, Janine McMillan, & Angeline Bartholomeusz. (2003). The Hepatitis B Virus and Common Mutants. Seminars in Liver Disease. 23(1). 5–20. 100 indexed citations
13.
Cooley, Louise, Anna Ayres, Angeline Bartholomeusz, et al.. (2003). Prevalence and characterization of lamivudine-resistant hepatitis B virus mutations in HIV–HBV co-infected individuals. AIDS. 17(11). 1649–1657. 53 indexed citations
14.
Lau, George, Ming‐Liang He, Dyt Fong, et al.. (2002). Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation. Hepatology. 36(3). 702–709. 135 indexed citations
15.
Locarnini, Stephen & Angeline Bartholomeusz. (2002). Advances in hepatitis C: What is coming in the next 5 years?. Journal of Gastroenterology and Hepatology. 17(4). 442–447. 11 indexed citations
16.
Aye, Thein Thein, Angeline Bartholomeusz, Tim Shaw, et al.. (1997). Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. Journal of Hepatology. 26(5). 1148–1153. 129 indexed citations
17.
Bartholomeusz, Angeline, Leo C. Groenen, & Stephen Locarnini. (1997). Clinical Experience with Famciclovir against Hepatitis B Virus. Intervirology. 40(5-6). 337–342. 38 indexed citations
18.
Bartholomeusz, Angeline, E. Tomlinson, P.J. Wright, et al.. (1994). Use of a Flavivirus RNA-dependent RNA polymerase assay to investigate the antiviral activity of selected compounds. Antiviral Research. 24(4). 341–350. 15 indexed citations
19.
Bartholomeusz, Angeline & P.J. Wright. (1993). Synthesis of dengue virus RNA in vitro: initiation and the involvement of proteins NS3 and NS5. Archives of Virology. 128(1-2). 111–121. 83 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen Locarnini Breakdown of academic impact, for papers by George G. Schlauder Breakdown of academic impact, for papers by Anna Kramvis Breakdown of academic impact, for papers by Gavin Cloherty Breakdown of academic impact, for papers by Carla Osiowy Breakdown of academic impact, for papers by Doris C. Wong Breakdown of academic impact, for papers by Michelle L. Chalmers Breakdown of academic impact, for papers by J. Saldanha Breakdown of academic impact, for papers by Scott Muerhoff Breakdown of academic impact, for papers by Erwin Sablon
Rankless by CCL
2026